{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:06:40Z","timestamp":1789996000284,"version":"4.0.1"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1093\/jac\/dki266","type":"journal-article","created":{"date-parts":[[2005,7,27]],"date-time":"2005-07-27T02:33:27Z","timestamp":1122431607000},"page":"455-462","source":"Crossref","is-referenced-by-count":160,"title":["Surveillance and epidemiology of MRSA bacteraemia in the UK"],"prefix":"10.1093","volume":"56","author":[{"given":"Alan P.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Duckworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,7,26]]},"reference":[{"key":"key\n\t\t\t\t20171012164311_B1","doi-asserted-by":"crossref","unstructured":"Barber M, Rozwadowska-Dowzenko M. Infection by penicillin-resistant staphylococci. Lancet1948; ii: 641\u20134.","DOI":"10.1016\/S0140-6736(48)92166-7"},{"key":"key\n\t\t\t\t20171012164311_B2","doi-asserted-by":"crossref","unstructured":"Henwood CJ, Livermore DM, Johnson AP et al. Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. J Antimicrob Chemother2000; 46: 931\u201340.","DOI":"10.1093\/jac\/46.6.931"},{"key":"key\n\t\t\t\t20171012164311_B3","doi-asserted-by":"crossref","unstructured":"Livermore DM, Mushtaq S, James D et al. In vitro activity of piperacillin\/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles. Int J Antimicrob Agents2003; 22: 14\u201327.","DOI":"10.1016\/S0924-8579(03)00108-0"},{"key":"key\n\t\t\t\t20171012164311_B4","doi-asserted-by":"crossref","unstructured":"Rolinson GN. Forty years of \u03b2-lactam research. J Antimicrob Chemother1998; 41: 589\u2013603.","DOI":"10.1093\/jac\/41.6.589"},{"key":"key\n\t\t\t\t20171012164311_B5","doi-asserted-by":"crossref","unstructured":"Jevons MP. Celbenin-resistant staphylococci. BMJ1961; i: 124\u20135.","DOI":"10.1136\/bmj.1.5219.124-a"},{"key":"key\n\t\t\t\t20171012164311_B6","doi-asserted-by":"crossref","unstructured":"Brown DF, Reynolds PE. Intrinsic resistance to \u03b2-lactam antibiotics in Staphylococcus aureus. FEBS Lett1980; 122: 275\u20138.","DOI":"10.1016\/0014-5793(80)80455-8"},{"key":"key\n\t\t\t\t20171012164311_B7","doi-asserted-by":"crossref","unstructured":"Marples RR, Reith S. Methicillin-resistant Staphylococcus aureus in England and Wales. CDR Rev1992; 2: R25\u20139.","DOI":"10.2165\/00002512-199202050-00001"},{"key":"key\n\t\t\t\t20171012164311_B8","doi-asserted-by":"crossref","unstructured":"Shanson DC. Antibiotic-resistant Staphylococcus aureus. J Hosp Infect1981; 2: 11\u201336.","DOI":"10.1016\/0195-6701(81)90003-7"},{"key":"key\n\t\t\t\t20171012164311_B9","unstructured":"Grant AD, Eke B. Application of information technology to the laboratory reporting of communicable disease in England and Wales. CDR Rev1993; 3: R75\u20138."},{"key":"key\n\t\t\t\t20171012164311_B10","unstructured":"Henry R. CoSurv: a regional strategy for communicable disease surveillance. PHLS Microbiol Digest1996; 13: 26\u20138."},{"key":"key\n\t\t\t\t20171012164311_B11","doi-asserted-by":"crossref","unstructured":"Speller DCE, Johnson AP, James D et al. Increasing resistance to methicillin and other antibiotics of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989\u20131995. Lancet1997; 350: 323\u20135.","DOI":"10.1016\/S0140-6736(97)12148-1"},{"key":"key\n\t\t\t\t20171012164311_B12","doi-asserted-by":"crossref","unstructured":"Johnson AP, James D. Continuing increase in invasive methicillin-resistant infection. Lancet1997; 350: 1710.","DOI":"10.1016\/S0140-6736(05)64319-X"},{"key":"key\n\t\t\t\t20171012164311_B13","doi-asserted-by":"crossref","unstructured":"Johnson AP, James D, Livermore DM. Increasing prevalence of methicillin resistance amongst Staphylococcus aureus blood culture isolates. J Antimicrob Chemother1999; 43: 160.","DOI":"10.1093\/jac\/43.1.160"},{"key":"key\n\t\t\t\t20171012164311_B14","doi-asserted-by":"crossref","unstructured":"Reacher MH, Shah A, Livermore DM et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ2000; 320: 213\u20136.","DOI":"10.1136\/bmj.320.7229.213"},{"key":"key\n\t\t\t\t20171012164311_B15","unstructured":"Health Protection Agency. Staphylococcus aureus bacteraemia: England, Wales and Northern Ireland, January to December 2002. CDR Wkly2004; 13: 5\u201310. http:\/\/www.hpa.org.uk\/cdr\/archives\/2003\/cdr1203.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B16","unstructured":"Health Protection Agency. Staphylococcus aureus bacteraemia: England, Wales and Northern Ireland: January to December 2003. CDR Wkly2004; 14: 8\u201312. http:\/\/www.hpa.org.uk\/cdr\/archives\/2004\/cdr1604.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B17","unstructured":"Health Protection Agency. Staphylococcus aureus Bacteraemia Laboratory Reports and Methicillin Susceptibility (Voluntary Reporting Scheme): England and Wales, 1990\u20132003. http:\/\/www.hpa.org.uk\/infections\/topics_az\/staphylo\/lab_data_staphyl.htm (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B18","unstructured":"Public Health Laboratory Service. Antimicrobial Resistance in 2000: England and Wales. http:\/\/www.hpa.org.uk\/infections\/topics_az\/antimicrobial_resistance\/amr.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B19","unstructured":"Scottish Centre for Infection and Environmental Health. Scottish antimicrobial resistance surveillance (SARS). SCIEH Wkly Rep2002; 36: 73\u20135. http:\/\/www.show.scot.nhs.uk\/scieh\/PDF\/pdf2002\/0211.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B20","doi-asserted-by":"crossref","unstructured":"Khairulddin N, Bishop L, Lamagni TL et al. Emergence of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia among children in England and Wales, 1990\u20132001. Arch Dis Child2004; 89: 378\u20139.","DOI":"10.1136\/adc.2003.028712"},{"key":"key\n\t\t\t\t20171012164311_B21","unstructured":"Department of Health. Surveillance of Healthcare-associated Infections. CMO's Update 30. May 2001.http:\/\/www.dh.gov.uk\/assetRoot\/04\/01\/36\/52\/04013652.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B22","unstructured":"Health Protection Agency. First report of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS Trusts in England: April to September 2001. CDR Wkly2003; 12: 1\u201315. http:\/\/www.hpa.org.uk\/cdr\/archives\/2002\/cdr0602.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B23","unstructured":"Health Protection Agency. The second year of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS Trusts in England: April 2002\u2013March 2003. CDR Wkly2003; 13: 7\u201315. http:\/\/www.hpa.org.uk\/cdr\/archives\/2003\/cdr2503.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B24","unstructured":"Health Protection Agency. The third year of regional and national analyses of the Department of Health's mandatory MRSA surveillance scheme in England: April 2001-March 2004. CDR Wkly2004; 14: 8\u201314. http:\/\/www.hpa.org.uk\/cdr\/archives\/2004\/cdr2904.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B25","unstructured":"Health Protection Agency. Results of the First Three and a Half Years of the Department of Health's Mandatory Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance System in Acute Trusts in England. http:\/\/www.hpa.org.uk\/infections\/topics_az\/staphylo\/staphyl_six_monthly.htm (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B26","unstructured":"Health Protection Agency. The fourth year of regional and national analyses of the Department of Health's mandatory Staphylococcus aureus surveillance scheme in England: April 2001\u2013March 2005. CDR Wkly2004; 15: 1\u20134. http:\/\/www.hpa.org.uk\/cdr\/archives\/2005\/cdr2505.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B27","unstructured":"National Public Health Service for Wales. Staphylococcus aureus bacteraemia surveillance report. 14th Report.http:\/\/www.wales.nhs.uk\/sites\/page.cfm?orgid=379&pid=5362 (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B28","unstructured":"Scottish Centre for Infection and Environmental Health. First Report on Methicillin-resistant Staphylococcus aureus Bacteraemia in Scotland, January to December 2001. http:\/\/www.show.scot.nhs.uk\/scieh\/infectious\/hai\/MRSA_quarter_reports\/FirstReportMRSA\/BookletMRSAAmendedA4.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B29","unstructured":"Communicable Disease Surveillance Centre Northern Ireland. First Report on MRSA Blood Cultures in Northern Ireland, April 2001\u2013 March 2002. http:\/\/www.cdscni.org.uk\/publications\/AnnualReports\/pdf\/1st%20report%20MRSA%20Blood%20Cultures%20NI.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B30","unstructured":"Health Protection Scotland. Methicillin-resistant Staphylococcus aureus in Scotland. Changes to the Surveillance System and Report of Health Protection Scotland's (HPS) Scottish Surveillance of Healthcare-Associated Infection Programme (SSHAIP). http:\/\/www.show.scot.nhs.uk\/scieh\/infectious\/hai\/MRSA_quarter_reports\/ChangesJan2005.pdf) (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B31","unstructured":"Scottish Centre for Infection and Environmental Health. Report on Methicillin-resistant Staphylococcus aureus Bacteraemia in Scotland, January 2002 to December 2002. http:\/\/www.show.scot.nhs.uk\/scieh\/infectious\/hai\/MRSA_quarter_reports\/MRSAapril03\/MRSA_Scot_Apr_03.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B32","unstructured":"Scottish Centre for Infection and Environmental Health. Report on Methicillin-resistant Staphylococcus aureus Bacteraemia in Scotland, January 2003 to December 2003. http:\/\/www.show.scot.nhs.uk\/scieh\/infectious\/hai\/MRSA_quarter_reports\/MRSA_Apr_04\/BookletA4.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B33","unstructured":"Health Protection Scotland. Quarterly Report on Methicillin-resistant Staphylococcus aureus Bacteraemia in Scotland. January 2001\u2013September 2004. http:\/\/www.show.scot.nhs.uk\/scieh\/infectious\/hai\/MRSA_quarter_reports\/MRSA_Apr05\/MRSAApr2005.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B34","unstructured":"Communicable Disease Surveillance Centre Northern Ireland. Report on Methicillin-resistant Staphylococcus aureus (MRSA) Blood Cultures in Northern Ireland: April 2002\u2013March 2003 (year 2). http:\/\/www.cdscni.org.uk\/publications\/AnnualReports\/pdf\/2nd%20report%20MRSA%20Blood%20Cultures%20NI%20.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B35","unstructured":"Communicable Disease Surveillance Centre Northern Ireland. Report on Methicillin-resistant Staphylococcus aureus (MRSA) Blood Cultures in Northern Ireland: April 2003\u2013March 2004 (year 3). http:\/\/www.cdscni.org.uk\/publications\/AnnualReports\/pdf\/3rd%20report%20MRSA%20Blood%20Cultures%20NI.pdf (25 April 2005, date last accessed)"},{"key":"key\n\t\t\t\t20171012164311_B36","doi-asserted-by":"crossref","unstructured":"Fluit AC, Wielders CL, Verhoef J et al. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol2001; 39: 3727\u201332.","DOI":"10.1128\/JCM.39.10.3727-3732.2001"},{"key":"key\n\t\t\t\t20171012164311_B37","doi-asserted-by":"crossref","unstructured":"Fluit AC, Schmitz FJ, Verhoef J. Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients. Eur J Clin Microbiol Infect Dis2001; 20: 188\u201391.","DOI":"10.1007\/s100960100455"},{"key":"key\n\t\t\t\t20171012164311_B38","doi-asserted-by":"crossref","unstructured":"Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997\u20132002). Diagn Microbiol Infect Dis2004; 50: 59\u201369.","DOI":"10.1016\/j.diagmicrobio.2004.05.003"},{"key":"key\n\t\t\t\t20171012164311_B39","unstructured":"European Antimicrobial Resistance Surveillance System (EARSS). http:\/\/www.earss.rivm.nl (25 April 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B40","unstructured":"British Society for Antimicrobial Chemotherapy. BSAC Resistance Surveillance: Bacteraemia Menu. http:\/\/www.bsacsurv.org\/ (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B41","doi-asserted-by":"crossref","unstructured":"Reynolds R, Potz N, Colman M et al. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001\u20132002: the BSAC Bacteraemia Resistance Surveillance Programme. J Antimicrob Chemother2004; 53: 1018\u201332.","DOI":"10.1093\/jac\/dkh232"},{"key":"key\n\t\t\t\t20171012164311_B42","unstructured":"Reynolds R, Livermore D, BSAC Working Party on Bacteraemia Resistance Surveillance. Comparative activity of BAL9141, daptomycin and linezolid versus S. aureus from bacteremias in the UK and Ireland. In Abstracts of the Forty-fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2004. Abstract E-2035, p. 180. American Society for Microbiology, Washington, DC, USA."},{"key":"key\n\t\t\t\t20171012164311_B43","unstructured":"Nosocomial Infection National Surveillance Service. Surveillance of Hospital-acquired Bacteraemia in English Hospitals, 1997\u20132002. http:\/\/www.hpa.org.uk\/infections\/publications\/ninns\/hosacq_HAB_2002.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B44","doi-asserted-by":"crossref","unstructured":"Cooke EM, Casewell MW, Emmerson AM et al. Methicillin-resistant Staphylococcus aureus in the UK and Ireland. J Hosp Infect1986; 8: 143\u20138.","DOI":"10.1016\/0195-6701(86)90040-X"},{"key":"key\n\t\t\t\t20171012164311_B45","doi-asserted-by":"crossref","unstructured":"Marples RR, Richardson JF, de Saxe MJ. Bacteriological characters of strains of Staphylococcus aureus to a reference laboratory related to methicillin resistance. J Hyg (Lond)1986; 96: 217\u201323.","DOI":"10.1017\/S0022172400065980"},{"key":"key\n\t\t\t\t20171012164311_B46","doi-asserted-by":"crossref","unstructured":"Kerr S, Kerr GE, Mackintosh CA et al. A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales. J Hosp Infect1990; 16: 35\u201348.","DOI":"10.1016\/0195-6701(90)90047-R"},{"key":"key\n\t\t\t\t20171012164311_B47","doi-asserted-by":"crossref","unstructured":"Richardson JF, Reith S. Characterisation of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. J Hosp Infect1993; 25: 45\u201352.","DOI":"10.1016\/0195-6701(93)90007-M"},{"key":"key\n\t\t\t\t20171012164311_B48","doi-asserted-by":"crossref","unstructured":"Cox RA, Conquest C, Mallaghan C et al. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect1995; 29: 87\u2013106.","DOI":"10.1016\/0195-6701(95)90191-4"},{"key":"key\n\t\t\t\t20171012164311_B49","doi-asserted-by":"crossref","unstructured":"Johnson AP, Aucken HM, Cavendish S et al. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: Analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J Antimicrob Chemother2001; 48: 143\u20134.","DOI":"10.1093\/jac\/48.1.143"},{"key":"key\n\t\t\t\t20171012164311_B50","unstructured":"Reference Laboratory for Methicillin-resistant Staphylococcus aureus. Annual Report, 1 April 2001 to 31 March 2002. http:\/\/www.show.scot.nhs.uk\/smrsarl\/annrpt01_02.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B51","doi-asserted-by":"crossref","unstructured":"Aucken HM, Ganner M, Murchan S et al. A new multi-resistant epidemic strain of methicillin-resistant Staphylococcus aureus (EMRSA-17). J Antimicrob Chemother2002; 50: 171\u20135.","DOI":"10.1093\/jac\/dkf117"},{"key":"key\n\t\t\t\t20171012164311_B52","doi-asserted-by":"crossref","unstructured":"Enright MC, Day NPJ, Davies CE et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol2000; 38: 1008\u201315.","DOI":"10.1128\/JCM.38.3.1008-1015.2000"},{"key":"key\n\t\t\t\t20171012164311_B53","doi-asserted-by":"crossref","unstructured":"Enright MC, Robinson DA, Randle G et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA2002; 99: 7687\u201392.","DOI":"10.1073\/pnas.122108599"},{"key":"key\n\t\t\t\t20171012164311_B54","doi-asserted-by":"crossref","unstructured":"Holden MT, Feil EJ, Lindsay JA et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA2004; 101: 9786\u201391.","DOI":"10.1073\/pnas.0402521101"},{"key":"key\n\t\t\t\t20171012164311_B55","doi-asserted-by":"crossref","unstructured":"Combined Working Party of the British Society for Microbiology, the Hospital Infection Society and the Infection Control Nurses Association. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect1998; 39: 253\u201390.","DOI":"10.1016\/S0195-6701(98)90293-6"},{"key":"key\n\t\t\t\t20171012164311_B56","doi-asserted-by":"crossref","unstructured":"Monnet DL, MacKenzie FJ, L\u00f3pez-Lozano JM et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996\u20132000. Emerg Infect Dis2004; 10: 1432\u201341.","DOI":"10.3201\/eid1008.020694"},{"key":"key\n\t\t\t\t20171012164311_B57","doi-asserted-by":"crossref","unstructured":"Weber SG, Gold HS, Hooper DC et al. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis2003; 9: 1415\u201322.","DOI":"10.3201\/eid0911.030284"},{"key":"key\n\t\t\t\t20171012164311_B58","doi-asserted-by":"crossref","unstructured":"H\u00f8iby N, Jarl\u00f8v JO, Kemp M et al. Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet1997; 349: 167\u20139.","DOI":"10.1016\/S0140-6736(96)09229-X"},{"key":"key\n\t\t\t\t20171012164311_B59","doi-asserted-by":"crossref","unstructured":"Bisognano C, Vaudaux P, Rohner P et al. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother2000; 44: 1428\u201337.","DOI":"10.1128\/AAC.44.6.1428-1437.2000"},{"key":"key\n\t\t\t\t20171012164311_B60","unstructured":"National Public Health Service for Wales. Staphylococcus aureus Bacteraemia Surveillance Report. Specialty Data.http:\/\/www.wales.nhs.uk\/sites\/page.cfm?orgid=379&pid=5362 (28 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B61","doi-asserted-by":"crossref","unstructured":"Cox RA, Mallaghan C, Conquest C et al. Epidemic methicillin-resistant Staphylococcus aureus: controlling the spread outside hospital. J Hosp Infect1995; 29: 107\u201319.","DOI":"10.1016\/0195-6701(95)90192-2"},{"key":"key\n\t\t\t\t20171012164311_B62","doi-asserted-by":"crossref","unstructured":"Cox RA, Bowie PES. Methicillin-resistant Staphylococcus aureus colonization in nursing home residents: A prevalence study in Northamaptonshire. J Hosp Infect1999; 43: 115\u201322.","DOI":"10.1053\/jhin.1999.0633"},{"key":"key\n\t\t\t\t20171012164311_B63","unstructured":"Alliance for the Prudent Use of Antibiotics. Focus: MRSA in the community (CMRSA). APUA Newslett2003; 21: 1\u20136. http:\/\/www.tufts.edu\/med\/apua\/Newsletter\/APUA_v21n2.pdf (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B64","doi-asserted-by":"crossref","unstructured":"Gwynne-Jones DP, Stott NS. Community-acquired methicillin-resistant Staphylococcus aureus: a cause of musculoskeletal sepsis in children. J Pediatr Orthop1999; 19: 413\u20136.","DOI":"10.1097\/01241398-199905000-00025"},{"key":"key\n\t\t\t\t20171012164311_B65","doi-asserted-by":"crossref","unstructured":"Salmenlinna S, Lyytikainen O, Vuopio-Varkila J. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis2002; 8: 602\u20137.","DOI":"10.3201\/eid0806.010313"},{"key":"key\n\t\t\t\t20171012164311_B66","doi-asserted-by":"crossref","unstructured":"Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis2003; 9: 978\u201384.","DOI":"10.3201\/eid0908.030089"},{"key":"key\n\t\t\t\t20171012164311_B67","unstructured":"Health Protection Agency. Community MRSA in England and Wales: Definition through Strain Characterisation. http:\/\/www.hpa.org.uk\/cdr\/archives\/archive05\/News\/news1105.htm#CMRSA (28 June 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012164311_B68","unstructured":"Kearns AM, Rathmann IR, Holmes A et al. An unusual clone of MRSA causing infection in injecting drug users. J Infect2004; 49: 49\u201350."},{"key":"key\n\t\t\t\t20171012164311_B69","doi-asserted-by":"crossref","unstructured":"Woodhead M, Fleming D, Wise R. Antibiotics, resistance, and clinical outcomes. BMJ2004; 328: 1270\u20131.","DOI":"10.1136\/bmj.328.7451.1270"},{"key":"key\n\t\t\t\t20171012164311_B70","unstructured":"Department of Health. Mandatory Surveillance of Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemias. http:\/\/www.dh.gov.uk\/assetRoot\/04\/11\/25\/90\/04112590.pdf (28 June 2005, date last accessed)."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/56\/3\/455\/2030134\/dki266.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T10:58:05Z","timestamp":1586343485000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/56\/3\/455\/691046\/Surveillance-and-epidemiology-of-MRSA-bacteraemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,26]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,7,26]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki266","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,7,26]]}}}